Science Explorer Interactive view Map
Company · Seoul · South Korea

Hanall Biopharma (South Korea)

en.hanall.co.kr/mainROR OpenAlex
Research works
45
▲ 66% vs 2013–17
Citations
677
15.0 per fractional work
Top-10% rate
16.3%
record average 16.5%
Open access
50%
world 28%

Not ranked overall: Hanall Biopharma (South Korea) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.15× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 5.86× its world share, 6 worksBiochemistry, Geneti…Immunology and Microbiology: 12.05× its world share, 2 worksImmunology and Micro…Neuroscience: 0.56× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 4.62× its world share, 0 worksPharmacology, Toxico…Computer Science: 0.42× its world share, 1 worksComputer ScienceEarth and Planetary Sciences: 0.35× its world share, 0 worksEarth and Planetary …Engineering: 0.36× its world share, 1 worksEngineeringMaterials Science: 1.13× its world share, 1 worksMaterials ScienceDentistry: 1.12× its world share, 0 worksDentistryMedicine: 2.02× its world share, 8 worksMedicineNursing: 1.58× its world share, 0 worksNursing1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 12.1×. Every wedge is a field page.

Which keywords describe research at Hanall Biopharma (South Korea)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Cancer, Immunotherapy, Tumor Microenvironment, Innate Immunity, Cancer Therapy, Transcriptional Regulation, Tumor Targeting and Cancer Immunotherapy.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 13 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 13 words, with their numbers
  1. Cancer2▲ 8.0×12 topics
  2. Immunotherapy2▲ 15×6 topics
  3. Tumor Microenvironment2▲ 17×5 topics
  4. Cancer Therapy2▲ 12×7 topics
  5. Innate Immunity2▲ 23×4 topics
  6. Inflammation1▲ 3.3×11 topics
  7. Transcriptional Regulation1▲ 43×4 topics
  8. Nanoparticles1▲ 5.0×5 topics
  9. Cancer Immunotherapy1▲ 39×3 topics
  10. Immunity1▲ 14×4 topics
  11. Tumor Targeting1▲ 34×3 topics
  12. Epidemiology1▲ 1.34×10 topics
  13. Oxidative Stress1▲ 3.1×5 topics

Which research topics does Hanall Biopharma (South Korea) publish most on?

By volume in 2022–2025: interferon and immune responses, Nanoplatforms for cancer theranostics, Immunotherapy and Immune Responses and Cancer-related gene regulation.

interferon and immune re…1interferon and immune responses: 1 fractional worksNanoplatforms for cancer…1Nanoplatforms for cancer theranostics: 1 fractional worksImmunotherapy and Immune…1Immunotherapy and Immune Responses: 1 fractional worksCancer-related gene regu…0Cancer-related gene regulation: 0 fractional worksHER2/EGFR in Cancer Research: 0 fractional worksCancer Immunotherapy and Biomarkers: 0 fractional worksRNA Interference and Gen…0RNA Interference and Gene Delivery: 0 fractional worksFerroptosis and cancer prognosis: 0 fractional worksAngiogenesis and VEGF in Cancer: 0 fractional worksCancer, Hypoxia, and Met…0Cancer, Hypoxia, and Metabolism: 0 fractional works
ImmunologyBiomedical EngineeringMolecular BiologyOncology2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 interferon and immune responses Immunology 1 works
  2. 2 Nanoplatforms for cancer theranostics Biomedical Engineering 1 works
  3. 3 Immunotherapy and Immune Responses Immunology 1 works
  4. 4 Cancer-related gene regulation Molecular Biology 0 works
  5. 5 HER2/EGFR in Cancer Research Oncology 0 works
  6. 6 Cancer Immunotherapy and Biomarkers Oncology 0 works
  7. 7 RNA Interference and Gene Delivery Molecular Biology 0 works
  8. 8 Ferroptosis and cancer prognosis Pulmonary and Respiratory Medicine 0 works
  9. 9 Angiogenesis and VEGF in Cancer Molecular Biology 0 works
  10. 10 Cancer, Hypoxia, and Metabolism Cancer Research 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available50.1%not open49.9%

World: 28% of research is openly available.

with international co-authors24.4%domestic only75.6%

World: 19% is written across borders.

How has Hanall Biopharma (South Korea)'s research output changed?

Output in 2018–2022 was 66% higher than in 2013–2017.

201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Seoul

All research institutions in Seoul

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.